In recent years, there has been growing interest in the tricuspid valve (TV), and
numerous studies have confirmed that severe tricuspid regurgitation (TR) is a clinically
significant disease associated with adverse outcomes.
1
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Canadian Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Tricuspid regurgitation in mitral valve disease incidence, prognostic implications, mechanism, and management.J Am Coll Cardiol. 2009; 53: 401-408
- Transcatheter edge-to-edge repair for treatment of tricuspid regurgitation.J Am Coll Cardiol. 2021; 77: 229-239
- Transcatheter interventions for tricuspid valve disease: what to do and who to do it on.Can J Cardiol. 2021; 37: 953-967
- transfemoral transcatheter tricuspid valve replacement.JACC Cardiovasc Interv. 2020; 13: e93-e94
- Early feasibility study of a transcatheter tricuspid valve annuloplasty: SCOUT trial 30-day results.J Am Coll Cardiol. 2017; 69: 1795-1806
- Transcatheter tricuspid valve intervention: a practical algorithm for patient selection.Curr Opin Cardiol. 2019; 34: 164-172
- 1-Year outcomes after edge-to-edge valve repair for symptomatic tricuspid regurgitation: results from the TriValve registry.JACC Cardiovasc Interv. 2019; 12: 1451-1461
- National trends and outcomes in isolated tricuspid valve surgery.J Am Coll Cardiol. 2017; 70: 2953-2960
- Management and outcomes of patients admitted with tricuspid regurgitation in France.Can J Cardiol. 2021; 37: 1078-1085
- Natural history of severe tricuspid regurgitation: outcomes after transcatheter tricuspid valve intervention compared to medical therapy.Int J Cardiol. 2020; 320: 49-54
- 2014 AHA/ACC guideline for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.J Am Coll Cardiol. 2014; 63: 2438-2488
- Combined valve operations in the aortic and mitral positions with or without added tricuspid valve repair.Semin Thorac Cardiovasc Surg. 2020;
- Tricuspid regurgitation and right ventricular function after mitral valve surgery with or without concomitant tricuspid valve procedure.J Thorac Cardiovasc Surg. 2013; 146: 1126-1132. e1110
- Concomitant tricuspid valve repair in patients with minimally invasive mitral valve surgery.Ann Cardiothorac Surg. 2013; 2: 758-764
- Impact of tricuspid regurgitation on long-term survival.J Am Coll Cardiol. 2004; 43: 405-409
Article info
Publication history
Published online: February 01, 2021
Accepted:
January 26,
2021
Received:
January 12,
2021
Footnotes
See article by Messika-Zeitoun et al., pages 1078–1085 of this issue.
See page 944 for disclosure information.
Identification
Copyright
© 2021 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Management and Outcome of Patients Admitted With Tricuspid Regurgitation in FranceCanadian Journal of CardiologyVol. 37Issue 7
